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Grb 10 Interacting GYF protein 2 (GIGYF2) is one of the novel protein that interacts 
with growth factor receptor bound protein 10 (Grb10), an adapter protein that binds 
activated insulin-like growth factor I (IGF-I) and insulin receptors. The interaction 
suggests that the gene to be potentially involved in insulin and IGF signaling. The 
GIGYF2 gene is located within a region linked to familial Parkinson’s disease (PARK11 
locus). Therefore, GIGYF2 represents a good candidate gene for PD. The expression of 
GIGYF2 gene was determined through RT-PCR of mRNA from ten isolated Danio rerio 
(zebrafish) organs, which include eye, gill, brain, heart, liver, intestine, stomach, skin, 
muscle and bone. The expression patterns of the GIGYF2 gene were compared between 
Danio rerio, human and mouse. Comparison showed that GIGYF2 gene was mainly 
expressed in insulin-targeted organs in Danio rerio and mammals. 
Key words: GIGYF2, Danio rerio, RT-PCR, expression patterns 
 
ABSTRAK 
Grb 10 Interacting GYF Protein 2 (GIGYF2) merupakan salah satu protein yang 
berinteraksi dengan Growth factor receptor bound protein 10 (Grb10), adaptor protein 
yang berikat dengan insulin-like growth factor I (IGF-1) dan reseptor insulin. Interaksi 
ini mencadangkan bahawa gen ini berpotensi dalam pemberian isyarat untuk 
menghasilkan insulin dan IGF. GIGYF2 terletak dalam satu lingkungan gen yang 
berkaitan dengan penyakit Parkinson (lokus PARK11). Oleh itu, GIGYF2 dicadangkan 
sebagai gen calon untuk PD. Ekspresi gen GIGYF2 ditentukan melalui kaedah RT-PCR 
menggunakan mRNA yang diekstrak dari sepuluh organ Danio rerio (zebrafish), 
termasuklah mata, insang, otak, jantung, hati, usus, perut, kulit, otot dan tulang. Corak-
corak ekspresi gen GIGYF2 dibandingkan antara Danio rerio dengan manusia dan tikus. 
Perbandingan ini telah menunjukkan gen GIGYF2 diekspreskan terutamanya di organ-
organ sasaran insulin. 






GIGYF 2 stands for Grb10 Interacting GYF protein 2. It is also known as PERQ 
amino acid-rich with GYF domain-containing protein 2 (PERQ2) and Trinucleotide 
repeat containing gene 15 protein (TNRC15) (UnitProtKB, 2009). Two novel proteins, 
GIGYF1 and GIGYF2, were found to interact with the Proline-rich region on Grb10 by 
using yeast two-hybrid screening (Giovannone et al., 2003). These two genes are 
homologous and they have similar structural motifs, including three potential tyrosine 
phosphorylation sites and candidate binding sites for protein phosphatase-1 (RVPF), 14-
3-3 proteins (RSpSXP), phospholipase Cγ (V(F)DDY), a proline-rich sequence (PRS), a 
consensus bipartite nuclear localization motive, and multiple stretches of Gln and Glu 
residues in the C-terminal half (Giovannone et al, 2003). GIGYF2 gene posses 1299 
amino acids and is encoded by 27 exons and 26 large introns (Lautier et al., 2008; 
Giovannone et al., 2003). 
The biological role of GIGYF family genes remain largely unclear (Kofler et al., 
2005). However, due to the interaction of 17-aa GYF domain with Grb10, there is a 
possibility that the gene may modulate of some cellular signaling such as tyrosine kinase 
receptor signaling and Grb10-mediated insulin-receptor signaling (Kofler & Freund, 2005; 
Giovannone et al., 2003). Recently, studies showed that proved that defects in GIGYF2 
gene could lead to type 11 Parkinson’s disease (PARK11) in Italian and French 
populations (Lautier et al., 2008). In addition, a research done by Giovannone et al. 
(2009), showed histopathological evidence that distruction of GIGYF2 gene in null mice 
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caused neurodegeneration in motor neurons, which is similar to neurodegeneration in 
Parkinson’s disease (PD) patients. Interestingly, the genotyping of GIGYF2 gene in 566 
PD patients and 1447 controls carried out by Nicholas et al. (2009) did not support the 
association between the variation in GIGYF2 gene and PD. Thus, the biological role of 
GIGYF2 gene remains controversial. 
In this project, zebrafish (Danio rerio) was chosen to characterize and study the 
expression of GIGYF2 gene. In the early 1970’s, Dr. George Streisinger had determined 
that zebrafish as a model organism for studying vertebrate development and genetics 
based on few advantageous features of zebrafish (Josephine, 2002; Heindel, 2000). The 
development of organs was very similar between zebrafish and human embryos (Heindel, 
2000). Moreover, zebrafish organs were similar to human organs (Badman et al., n.d.).  
The aims of this study include identifying the expression patterns of GIGYF2 
gene in zebrafish, followed by expression patterns comparison between mammals and 
non-mammals. This will serve as useful information for the functional study of GIGYF2 
gene. 
The objective of this project is to study and determine the expression patterns of 
GIGYF2 gene in zebrafish through total RNA isolation and reverse transcription 







2.1 Grb10 Interacting GYF Protein 2 (GIGYF2) 
GIGYF2 is a gene that can be found in human (Homo sapiens), dog (Canis 
familiaris), chimpanzee (Pan troglodytes), cow (Bos taurus), mouse (Mus musculus), and 
chicken (Gallus gallus) (GeneCard, 2009). Besides, Lee (2008) had identified the 
presence of GIGYF2 gene in zebrafish (Danio rerio). 
Human GIGYF2 gene is located on chromosome 2q36.1 and was designated 
TNRC15 (trinucleotide repeat containing 15) while GIGYF gene is located on 
chromosome 1 in mouse. However, the exact location of this gene in mouse is remained 
ambiguous (Giovannone et al., 2003). 
The biological role of GIGYF2 gene remains controversial, however it may act 
cooperatively with Grb10 to regulate tyrosine kinase receptor signaling, including 
insulin-like growth factor 1 (IGF-I) and insulin receptors (Giovannone et al., 2003). 
2.2 Growth Factor Receptor-bound Protein 10 (Grb10) 
Grb10 belongs to a small family of adapter proteins that are known to interact 
with receptor tyrosine kinase and other signaling molecules (Nantel et al., 1999). Grb10 
contains an N-terminal proline-rich region, a Ras-associating domain, a pleckstrin 
homology (PH) domain, a BPS (between PH and SH2) domain, and a C-terminal SH2 
domain (Liu & Roth, 1995). Proline-rich sequence (PRS) is the region that binds GIGYF 
to Grb10 (Giovannone et al, 2003). 
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Grb10 has a number of isoforms due to alternative splicing of the N terminus (Liu 
& Roth, 1995). These isoforms will bind to different intracellular domains and perform 
different functions, which include the activation of insulin, IGF-I, epidermal growth 
factor, growth hormone, and platelet-derived growth factor receptors (Hansen et al., 
1996). According to Dufresne (2005), IGF-I is critical for normal somatic growth and 
development in human. In her study, Grb10 knockdown cells had decreased in IGF-I-
stimulated receptor phoshorylation and increased DNA synthesis. This indicates that 
Grb10 functions as a specific endogenous suppressor of IGF-I-stimulated cell signaling 
and DNA synthesis (Dufresne, 2005). However, the biological role of Grb10 in this 
mechanism still unclear (Liu & Roth, 1995). 
2.3 GYF Domain Protein 
The GYF domain is named for a Glycine-Tyrosine-Phenyalanine triad. GYF 
domains are small, protein interaction domains of eukaryotic species that will recognize 
proline-rich sequences (PRS) (Kofler & Freund, 2005). Similar to other PRS-recognition 
domains (PRD), GYF domains bind to many different PRS that converge on a minimal 
consensus sequence (Kofler & Freund, 2005). All GYF domains select for the core motif 
PPG because PPG motifs contributes most of the Van der Waals interactions (Kofler et 
al., 2005). For GIGYF2, it requires the PPG (F/I/L/V) motif for the GYF domains (Kofler 
et al., 2005). GYF proteins are subdivided into two families, which are the CD2BP2-type 
and the SMY2-type subfamily. The binding site of GIGYF2 is SMY2-type GYF domains 
which has shorter β1-β2 loop and the presence of an aspartate instead of tryptophan at 
position 8 (Kofler & Freund, 2005). 
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2.4 GIGYF2 Expression 
 Recent data showed that GIGYF2 had highest abundance in heart and liver 
(Giovannone et al., 2003). The expression of GIGYF2 was done on multiple mouse tissue 
using Northern blotting experiments. A multiple tissue Northern blot containing poly(A)
+
 
mRNA isolated from various mouse tissues was probed with GIGYF2 fragment obtained 
from the original two-hybrid screening. There was a 7-kb transcript of the gene detected. 
The highest expression levels were found in heart and liver, while lower expression found 
in kidney and brain. Expression of GIGYF2 was barely detectable in lung. GIGYF2 
mRNA was not being detected in spleen and skeletal muscle of the mouse. The mRNA 
GIGYF2 was also found in testis (Giovannone et al., 2003). 
2.5 Parkinson’s Disease 
Parkinson’s disease (PD) is a common neurodegenerative disorder that infects 
approximately 15,000 to 20,000 individuals in Malaysia (Malaysia Parkinson’s Disease 
Association, 2009). PD is characterized by the loss of dopamine, which is one of the 
neurotransmitters that located in the substania nigra. The symptoms of PD include resting 
tremor, muscular rigidity and postural instability (Nada, 2008). At least 15 loci (PARK1-
PARK15) had been identified and numerous genes had been reported to cause familial 
PD (Guella et al., 2010). GIGYF2 gene located within PARK11 locus, thus it is possible 
to postulate that GIGYF2 could be a potential candidate PD gene (Tan et al., 2009). 
Mutations in the GIGYF2 gene at the PARK11 locus had been reported in 
familial Parkinson Disease (PD) (Lautier et al., 2008). Seven different GIGYF2 missense 
mutations were found in 123 Italian and 126 French familial PD patients, which were 
7 
 
absent in 318 controls supported GIGYF2 as a causal role in familial PD (Lautier et al., 
2008).  
In a research carried out by Giovannone et al. (2009), GIGYF2 gene was 
disrupted in mice and these null mice performed normal embryonic development, but 
died within the first two postnatal days. Heterozygous GIGYF2 mice survived until 
adulthood, but they began to exhibit motor dysfunction at 12 to 15 months of age 
(Giovannone et al., 2009). Histopathological evidence showed that the mice undergone 
neurodegeneration and rare intracytoplasmic Lewy body-like inclusions in spinal anterior 
horn motor neurons, which were the causes for PD (Giovannone et al., 2009). On the 
other hand, GIGYF2 null mice had decreased level of IGF-I-stimulated IGF-I receptor 
tyrosine phosphorylation and augmented ERK1/2 phosphorylation (Giovannone et al., 
2009). This research strongly suggested that GIGYF2 gene as a candidate gene for PD 
and the important role of GIGYF2 gene in IGF pathway signaling (Giovannone et al., 
2009). 
However, there were several researches showed that GIGYF2 gene was unlikely 
to be the causal factor for familial PD. The genetic analysis of GIGYF2 gene in 450 PD 
patients (including familial and sporadic PD patients) and 400 controls from Singapore 
and Taiwan revealed 17 variants, where ten of these were novel variants and seven had 
been previously reported by Lautier et al. (2008). Among 450 PD patients, seven patients 
were non-synonymous variants. However, only one out of seven patients had a positive 
family history of PD. This data strongly excluded GIGYF2 as a contributory factor to 
familial PD gene (Tan et al., 2009). 
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Moreover, the research carried out by Nichols et al. (2009) did not support the 
association between the variation in GIGYF2 and PD. Sequencing of GIGYF2 coding 
region in 96 PD patients and genotyping of the samples from 566 PD patients and 1447 
controls did not provide a significant increase in risk for PD among the inheriting variants 
in GIGYF2 (Nichols et al., 2009). 
Mutational screening of GIGYF2 gene in a large Italian population and functional 
study of the gene using Danio rerio mdel did not support the fact that GIGYF2 gene as a 
candidate gene for PD (Guella et al., 2010). In mutational screening of GIGYF2 gene in 
552 PD patients and 552 controls, eight different missense mutations in a total of nine 
individuals (four PD patients and five controls) were found. In addition, the destruction 
of GIGYF2 gene in Danio rerio embryos by morpholino oligonucleotide injection did not 
cause a drastic loss of neurons in diencephalic dopaminergic (DA) neuron clusters. Thus, 
the data suggested that GIGYF2 gene is unlikely to be the PARK11 gene (Guella et al., 
2010). 
2.6 Zebrafish (Danio rerio) 
 The binomial name of zebrafish is Danio rerio (Mayden et al., 2007). Zebrafish is 
a new model organism for studies of regulatory physiology, vertebrate development, 
disease, biological pathways and toxicological mechanisms (Heindel, 2000). The 
zebrafish is vertebrate and consists of the organs which are similar to human body 
(Badman et al., n.d.).  
Zebrafish has many advantages over other vertebrate model organisms, such as 
mouse and frogs, including a shorter life cycle and producing more offsprings in a shorter 
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time (Twyman, 2002). Besides, zebrafish is small, freshwater fish that can be easily 
maintained in aquariums (Josephine, 2002). 
According to Sprague et al. (2001) from the University of Oregon, zebrafish 
emerged as a premier model organism because powerful techniques allow efficient 
generation and recovery of zebrafish mutations affecting genes that regulate 
developmental patterning, organogenesis, physiology and behavior. Induction of new 
mutations in zebrafish and large-scale screens can identify mutations causing defects in 
particular biological processes, such as the developing nervous system (Twyman, 2002). 
These advantages allowed the creation of dense genetic maps in the zebrafish, which 
have been useful for the comparative mapping of human genes (Twyman, 2002). Besides, 
recent advances make it easy to study gene function by generating transgenic zebrafish or 
by knocking down gene using morpholino antisense oligonucleotides. Since functions of 
many genes are conserved among vertebrate groups, the analysis of zebrafish mutations 
provides an indication to the gene functions in other vertebrates, including humans 





MATERIALS AND METHODS 
3.1 Primer Design 
In order to perform Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) 
in future, forward and reverse primers were designed. Two programmes were used, 
including the Primer3 web primer tool (http://frodo.wi.mit.edu/primer3/). cDNA 
sequence of GIGYF2 was pasted on the query box, then the product size was changed to 
450 to 550 basepairs before the primer design was performed. 
After that, all primers obtained from Primer3 were analysed using NetPrimer, a 
free primer analysis software (http://www.premierbiosoft.com/netprimer/index.html). 
Primers which were 20 bp long was pasted to the “sequence 5’-3’” box and analyzed. The 
analysis of the primers provided the rating for each primer. Rating above 80 is considered 
good for amplification. The pair of primers with highest rating will be chosen to perform 
Reverse Transcription Polymerase Chain Reaction (RT-PCR).  
After the primers were identified, annealing temperatures (Tm) of the forward and 
reverse primers were calculated using the following calculations: 
Annealing temperature (Tm) = 4(G+C) + 2(T+A) – 5ºC 
                              






3.2 Total RNA Isolation 
Ten sterile eppendorf tubes were prepared and labeled. Each of the tube was 
added with 1 ml of TriReagent. Six zebrafish were dissected and the organs (eye, gill, 
brain, heart, liver, intestine, stomach, skin, muscle, and bone) were added into separating 
tubes according to the labeling. The samples were incubated at room temperature for five 
minutes to permit complete dissociation of nucleoprotein complexes. After that, the 
samples were centrifuged at 12,000 rpm at 4ºC for 10 minutes. 200 µl of chloroform was 
added into each tube and the tubes were shaken vigorously by hands for 15 seconds. The 
samples were incubated at room temperature for five minutes and then centrifuged at 
12,000 rpm for 15 minutes at 4 ºC. 
After centrifugation, the aqueous phase was transferred into a fresh eppendorf 
tube and 500 µl of cold isopropyl alcohol was added. The samples were incubated at 
room temperature for 10 minutes followed by centrifugation at 12,000 rpm for 10 
minutes at 4 ºC. The RNA precipitate often invisible before centrifugation, but the RNA 
formed a gel-like pellet on the side of tube after the centrifugation. Supernatant was 
discarded and the RNA pellet was wash with 75% ethanol. The samples were mixed by 
vortexing. Then, the mixtures were centrifuged at 7,500 rpm for five minutes at 4 ºC. 
RNA pellet was air-dried for approximately 15 minutes before dissolved in 10 µl 
RNase-free water. The extracted RNA was stored in -20 ºC or -70 ºC for long-term 
storage. 2 µl of the RNA was run on an agarose gel electrophoresis to visualize the RNA 




3.3 Agarose Gel Electrophoresis (AGE) 
1% agarose gel was prepared to run the RNA samples from 10 different organs of 
zebrafish. 0.5 g agarose powder was dissolved in 50 ml 1xTAE buffer. The mixture was 
heated in microwave oven for two minutes for complete dissolve of the agarose powder. 
The mixture was cooled at room temperature until it was approximately 60 ºC. 2 µl of 
ethidium bromide was added and the bottle was swirled. Then, the mixture was poured 
into the gel case. After the gel was formed, RNA samples were loaded into different well. 
For every well, it contained 2 µl of 6x loading dye, 6 µl of distilled water and 2 µl of 
sample. The mixture was mixed well using 10 µl pipette and then loaded into the well. 
Next, the gel was run at 120V for approximately 30 minutes in 1xTAE buffer (until the 
loading dye reach ¾ of the gel). The gel was visualized using transilluminator and 
documented using a black and white video camera system. 
3.4 Purification of RNA using Phenol/chloroform/isoamylalcohol Method 
The RNA samples that did not show clear bands were subjected to the purification 
steps. 8 µl of the sample left from AGE was added with 492 µl distilled water to make up 
a total amount of the 500 µl sample. An equal volume of phenol/chloroform/isoamyl 
alcohol (PCI) was added and mixed using a vortex machine. The emulsion was 
centrifuged at 12,000 rpm for five minutes at 4 ºC.  
After that, the aqueous supernatant was transferred into a new tube. The amount 
of the supernatant was approximately 400 µl. An equal volume of chloroform (400 µl) 
was added into the tube and the mixture was centrifuged at 12,000 rpm for five minutes 
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at 4 ºC. After the centrifugation, approximately 300 µl aqueous layer was collected into a 
new tube. 
For RNA precipitation, 30 µl of 3M sodium acetate (pH5.2) and 600 µl of cold 
100% ethanol were added into the tube. The mixture was then stored at -80 ºC for an hour. 
The RNA was recovered by centrifugation at 12,000 rpm for 15 minutes at 4ºC. Then, the 
supernatant was removed by decant. 
The RNA pellet was washed with 1 ml of 70% cold ethanol. The sample was 
centrifuged at 12,000 rpm for 5 minutes at 4 ºC and the supernatant was removed. The 
RNA pellet was dried at room temperature for 15 minutes before resuspended in 30 µl 
RNase-free water. The RNA sample was stored in -20 ºC or -80 ºC for long-term storage. 
2 µl of purified RNA was run on an agarose gel electrophoresis to analyze the purity of 
the RNA. 
3.5 RNA Quantification 
Extracted and purified RNA samples were quantified using spectrophotometer. 2 
µl of RNA samples were diluted with 68 µl distilled water in the cuvette and the 
absorbance values of 260 nm, 280 nm, and 320 nm were determined and recorded. The 
purity of the RNA samples was determined through calculation of A260-320/A280-320 ratio. 
The concentration of RNA was calculated using the equation below: 
                                  
        
    




3.6 cDNA Synthesis 
First-strand cDNA synthesis was prepared for Reverse Transcription Polymerase 
Chain Reaction (RT-PCR). To synthesis first-strand cDNA, ImProm-II
TM
 Reverse 
Transcription System (Promega) was used. 2 µl RNA sample and 1 µl random primer 
(0.5 µg/reaction) were mixed with 2 µl nuclease-free water. 1 µl of 1.2 kb Kanamycin 
Positive Control RNA and oligo (dT)15 Primer (0.5 µg/reaction) were used as positive 
control. Then, the mixtures were incubated in ESCO Swift MiniPro PCR machine at 70 
ºC for five minutes and chilled on ice for at least 5 minutes immediately after the 
incubation. 
After that, 15 µl reverse transcription reaction aliquots were prepared and mixed 
with 5 µl of primer mix to obtain a final reaction volume of 20 µl per tube. Reverse 
transcription reaction mix was stated clearly in Table 1 and the mixture of positive 
control was listed in Table 2. 
Experiment Reaction ×1 Master Mix (×12) 
Nuclease-Free Water (to a final volume of 15 µl) 6.35 µl 76.20 µl 
ImProm-II
TM
 5X Reaction Buffer 4.00 µl 48.00 µl 
MgCl2 (final concentration 4 mM) 2.40 µl 28.80 µl 
dNTP Mix (final concentration 0.5 mM) 0.75 µl 9.00 µl 
Recombinant RNasin
® 
Ribonuclease Inhibitor 0.50 µl 6.00 µl 
ImProm-II
TM 
Reverve Transcriptase 1.00 µl 12.00 µl 
Final volume 15.00 µl 180.00 µl 





Nuclease-Free Water (to a final volume of 15 µl) 5.15 µl 
ImProm-II
TM
 5X Reaction Buffer 4.00 µl 
MgCl2 (final concentration 6 mM) 3.60 µl 
dNTP Mix (final concentration 0.5 mM) 0.75 µl 
Recombinant RNasin
® 
Ribonuclease Inhibitor 0.50 µl 
ImProm-II
TM 
Reverve Transcriptase 1.00 µl 
Final volume 15.00 µl 
Table 2: Positive control of reverse transcription reaction mix 
The samples were then annealed at 25 ºC for five minutes, extended at 42 ºC for 
an hour and then inactivation of reverse transcriptase at 70 ºC for 15 minutes. 
3.7 Reverse Transcription Polymerase Chain Reaction (RT-PCR) 
First, the master mix for 12 reactions was prepared. All the components except 
cDNA template were added into the master mix. The components of the master mix and 
positive control were listed in Table 3. 
Components X1 Master Mix (×12) Positive-Control 
10× PCR Buffer minus Mg 
(final concentration 1×) 
2.50 µl 30.00 µl 2.50 µl 
10 mM dNTP mixture (final 
concentration 0.2 mM) 
0.50 µl 6.00 µl 0.50 µl 
50 mM MgCl2 (final 
concentration1.5 mM) 
0.75 µl 9.00 µl 0.75 µl 
10 µM Forward Primer (final 
concentration 0.5 µM) 
1.25 µl 15.00 µl 
1.25 µl (Upstream 
Control Primer) 
10 µm Reverse Primer (final 
concentration 0.5 µM) 
1.25 µl 15.00 µl 




Template DNA (cDNA) 1.50 µl - 1.50 µl 
Taq DNA Polymerase 0.20 µl 6.00 µl 0.50 µl 
Autoclaved distilled water 17.05 µl 204.60 µl 16.75 µl 
Final Volume 25.00 µl 300.00 µl 25.00 µl 
Table 3: Components of master mix and positive control. 
The complete sequence for GIGYF2 forward primer chosen was 5’-TGG ATG 
AGG ATG AGG GAC TC-3’, while for GIGYF2 reverse primer was 5’-GGA GGA 
GGA GGA GCA GAG TT-3’. The conditions for the amplification were summarized in 
Table 4. 
Initial template denaturation 95 ºC for 2 minutes  
Denaturation 94 ºC for 30 seconds             
     30 cycles Annealing 58 ºC for 1 minutes 
Extension 72 ºC for 1 minutes 
Final extension 72 ºC for 5 minutes  
Table 4: Contitions for RT-PCR amplification 
After the amplification, RT-PCR samples were run on 1.5% agarose gel 
electrophoresis and visualized using transilluminator. 
3.8 Comparison of GIGYF2 Gene Expression Pattern between Danio rerio and 
Other Species 
Visualisation of RT-PCR results showed expression pattern of GIGYF2 gene in 
Danio rerio. Thus, expression patterns of GIGYF2 gene in other species, such as mouse 
and human, were retrieved from the internet and compared with the expression pattern 
obtained. 
  
